Artiklar med krav på offentlig åtkomst - SILVANA ANDREA BELALCAZAR ARAUJOLäs mer
Inte tillgängliga någonstans: 32
Granska
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Krav: US National Institutes of Health
Granska
AJC editor's consensus: psoriasis and coronary artery disease
VE Friedewald, JC Cather, JM Gelfand, KB Gordon, GH Gibbons, ...
American Journal of Cardiology 102 (12), 1631-1643, 2008
Krav: US National Institutes of Health
Granska
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an …
PM Ridker, J MacFadyen, P Libby, RJ Glynn
The American journal of cardiology 106 (2), 204-209, 2010
Krav: US National Institutes of Health
Granska
Relationship of Interleukin-1Blockade With Incident Gout and Serum Uric Acid Levels
DH Solomon, RJ Glynn, JG MacFadyen, P Libby, T Thuren, BM Everett, ...
Annals of internal medicine 169 (8), 535-542, 2018
Krav: US National Institutes of Health
Granska
Lack of Association between SLCO1B1 Polymorphisms and Clinical Myalgia Following Rosuvastatin Therapy
JS Danik, DI Chasman, JG MacFadyen, F Nyberg, BJ Barratt, PM Ridker
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 21, 185-186, 2012
Krav: US National Institutes of Health, Doris Duke Charitable Foundation
Granska
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly (ADP-ribose) polymerase (INO …
DA Morrow, CM Brickman, SA Murphy, K Baran, R Krakover, H Dauerman, ...
Journal of thrombosis and thrombolysis 27 (4), 359-364, 2009
Krav: US National Institutes of Health
Granska
Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (< 30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER)
BM Everett, S Mora, RJ Glynn, J MacFadyen, PM Ridker
The American journal of cardiology 114 (11), 1682-1689, 2014
Krav: US National Institutes of Health
Granska
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or …
SR Wilson, MS Sabatine, SD Wiviott, KK Ray, JA De Lemos, S Zhou, ...
American heart journal 161 (6), 1147-1155. e1, 2011
Krav: US National Institutes of Health
Granska
Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial
BD Horne, JL Anderson, JB Muhlestein, PM Ridker, NP Paynter
European journal of preventive cardiology 22 (4), 519-526, 2015
Krav: US National Institutes of Health
Granska
The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA. CER) trial: study design and rationale
RA Harrington, F Van de Werf, PW Armstrong, P Aylward, E Veltri, ...
American heart journal 158 (3), 327-334, 2009
Krav: US National Institutes of Health
Granska
Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism
RYL Zee, SE Michaud, KA Diehl, DI Chasman, J Emmerich, P Gaussem, ...
Atherosclerosis 197 (2), 694-699, 2008
Krav: US National Institutes of Health
Granska
Nonfasting sample for the determination of routine lipid profile: is it an idea whose time has come?
N Rifai, IS Young, BG Nordestgaard, AS Wierzbicki, H Vesper, S Mora, ...
Clinical chemistry 62 (3), 428-435, 2016
Krav: UK Medical Research Council
Granska
Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England
CB Eaton, R Gramling, DR Parker, MB Roberts, B Lu, PM Ridker
Atherosclerosis 200 (1), 221-227, 2008
Krav: US National Institutes of Health
Granska
The JUPITER Trial: responding to the critics
PM Ridker, RJ Glynn
American Journal of Cardiology 106 (9), 1351-1356, 2010
Krav: US National Institutes of Health
Granska
The editor’s roundtable: psoriasis, inflammation, and coronary artery disease
VE Friedewald, JC Cather, KB Gordon, A Kavanaugh, PM Ridker, ...
American Journal of Cardiology 101 (8), 1119-1126, 2008
Krav: US National Institutes of Health
Granska
High-sensitivity troponin I in stable patients with atherosclerotic disease in the TRA 2° P-TIMI 50 trial
A Eisen, MP Bonaca, P Jarolim, BM Scirica, HD White, M Tendera, ...
Clinical chemistry 63 (1), 307-315, 2017
Krav: US Department of Agriculture
Granska
Should patients with rheumatoid arthritis receive statin therapy?
PM Ridker, DH Solomon
Arthritis & Rheumatism 60 (5), 1205-1209, 2009
Krav: US National Institutes of Health
Granska
Moving toward new statin guidelines in a post-JUPITER world: principles to consider
PM Ridker
Current atherosclerosis reports 11 (4), 249-256, 2009
Krav: US National Institutes of Health
Granska
The unmet need for addressing cardiac issues in intensive care research
S Van Diepen, CB Granger, M Jacka, IC Gilchrist, DA Morrow, JN Katz
Critical care medicine 43 (1), 128-134, 2015
Krav: Canadian Institutes of Health Research
Granska
Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: analysis from MERLIN-TIMI 36
MP Bonaca, RG O’Malley, SA Murphy, P Jarolim, MJ Conrad, ...
European Heart Journal: Acute Cardiovascular Care 4 (5), 431-440, 2015
Krav: US National Institutes of Health
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.